KMB Kimberly-Clark Corporation - Common Stock
Sobre Kimberly-Clark Corporation - Common Stock Visão geral da empresa da Wikipedia
Kimberly-Clark Corporation is an American multinational consumer goods and personal care corporation that produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes.
Ler mais
Kimberly-Clark Corporation is an American multinational consumer goods and personal care corporation that produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes.
Founded in Neenah, Wisconsin, in 1872 and based in the Las Colinas section of Irving, Texas, since 1985, the company operated its own paper mills around the world for decades, but closed the last of those in 2012. With recent annual revenues topping $18 billion per year, Kimberly-Clark is regularly listed among the Fortune 500. As of March 2020, the company had approximately 40,000 employees.
History
Kimberly, Clark and Co. was founded in 1872 by John A. Kimberly, Havilah Babcock, Charles B. Clark and Franklyn C. Shattuck in Neenah, Wisconsin, with $42,000 (equivalent to US$1,128,750 in 2025) of capital. The group's first business was operating paper mills, which the collective expanded throughout the following decades. In 1888, the fledgling company faced a significant setback when its groundwood "Atlas" paper mill burned. Through an extensive effort by labor and management, within five months the mill was rebuilt and in production at a greater capacity. In that same year the company began rapid expansion, purchasing land in a town then known as The Cedars for a new groundwood pulp plant designed by prominent paper mill architects D. H. & A. B. Tower. In 1889, the town was renamed Kimberly after John A. Kimberly. The company would also contract the firm to expand its vast sulphite pulp complex in Appleton, Wisconsin, which allowed it to become the first firm west of Pennsylvania to adopt this improved manufacturing process. The company developed cellu-cotton in 1914, a cotton substitute used by the U.S. Army as surgical cotton during World War I. Army nurses used cellu-cotton pads as disposable sanitary napkins, and six years later the company introduced Kotex, the first disposable feminine hygiene product. Kleenex, a disposable handkerchief, followed in 1924. Kimberly & Clark joined with The New York Times Company in 1926 to build a newsprint mill in Kapuskasing, Ontario, Canada. Two years later, the company went public as Kimberly-Clark.
The firm expanded internationally during the 1950s, opening plants in Mexico, West Germany and the United Kingdom. It began operations in 17 more foreign locations in the 1960s. The company formed Midwest Express Airlines from its corporate flight department in 1984. Kimberly-Clark's headquarters moved from Neenah, Wisconsin to Irving, Texas the following year, although its products are still produced in Neenah. Alongside Cadbury, Kimberly-Clark withdrew advertising support for Lou Grant in 1982, due to pressure from various conservative caucuses campaigning against star Ed Asner. Under the leadership of Darwin Smith as CEO from 1971 to 1991, the company was transformed from a business paper company to a consumer paper products company.
In 1991, Kimberly-Clark and The New York Times Company sold their jointly owned paper mill in Kapuskasing, Ontario. Kimberly-Clark entered a joint venture with Buenos Aires-based Descartables Argentinos S.A. to produce personal care products in Argentina in 1994 and also bought the feminine hygiene unit of VP-Schickedanz (Germany) for $123 million and a 90% stake in Handan Comfort and Beauty Group (China).
Kimberly-Clark merged with Scott Paper in 1995 for $9.4 billion. In 1997, Kimberly-Clark sold its 50% stake in Canada's Scott Paper to forest products company Kruger Inc. and bought diaper operations in Spain and Portugal and disposable surgical masks maker Tecnol Medical Products. Augmenting its presence in Germany, Switzerland and Austria, in 1999 the company paid $365 million for the tissue business of Swiss-based Attisholz Holding. Expanding its offerings of medical products, the company bought Ballard Medical Products in 1999 for $774 million and examination-glove maker Safeskin in 2000 for about $800 million.
Also in 2000, the company bought virtually all of Taiwan's S-K Corporation; the move made Kimberly-Clark one of the largest manufacturers of packaged goods in Taiwan. The company later purchased Taiwan Scott Paper Corporation for about $40 million and merged the two companies, forming Kimberly-Clark Taiwan. In 2001, Kimberly-Clark bought Italian diaper maker Linostar and announced it was closing four Latin American manufacturing plants.
In 2002, Kimberly-Clark purchased paper-packaging rival Amcor's stake in an Australian joint venture. In 2003, Kimberly-Clark added to its global consumer tissue business by acquiring the Polish tissue maker Klucze.
In early 2004, chairman and chief executive officer Thomas Falk began implementation of a global business plan that the company has detailed in July 2003. The firm combined its North American and European groups for personal care and consumer tissue under North Atlantic groups. In 2019, CEO Thomas Falk resigned his position but continued on as the company's chairman of the board. COO Michael D. Hsu became CEO following Falk's retirement.
As of March 2020, the company had approximately 40,000 employees. In April 2020, the Financial Times reported that panic-buying during the COVID-19 pandemic led to a 13 percent increase in sales of Kimberly-Clark's consumer tissues in the first quarter of 2020 compared with the previous year. In April 2020, Kimberly Clark reported an eight percent decline in organic sales, its worst sales performance in at least a decade, according to the Wall Street Journal.
In 2022, Kimberly-Clark acquired majority stake in Thinx, a period underwear brand. Sales declined significantly by 2022 as customers lost the brand's trust regarding the controversy behind the use of PFAS in its products, ending in a class action settlement in 2023. The company eventually recorded an asset impairment for Thinx and Softex Indonesia of $658 million in 2023.
On May 19, 2025, Kimberly-Clark announced that after 41 years, it would transfer its stock from the New York Stock Exchange to the Nasdaq Global Select Market with the changes taking place on May 30 of that year.
In November 2025, Kimberly-Clark announced it would buy Tylenol producer Kenvue for $48.7 billion. The deal would add the Aveeno, Band-Aid, Benadryl, Benylin, Calpol, Carefree, Clean & Clear, Combantrin, Imodium, Listerine, Motrin, Mylanta, Neutrogena, Nicorette, Johnson's Baby, Sudafed, Visine, and Zyrtec brands to the company's portfolio.
On April 7, 2026, the Kimberly-Clark Distribution Center in Ontario, California was set on fire and destroyed. This was filmed by the arsonist, who stated in the video, "all you had to do was pay us enough to live," and "there goes your inventory."
Ownership and subsidiaries
Kimberly-Clark shares are mainly held by institutional investors (The Vanguard Group, BlackRock, State Street Corporation, and others). Its subsidiaries include Kimberly-Clark Professional.
Midwest Airlines
The origin of Midwest Airlines can be traced back to 1948, when Kimberly-Clark opened its corporate flight department and began providing air transportation for company executives and engineers between the company's headquarters in Neenah and its paper mills.
In 1969, K-C Aviation was born from the company's air operations, and was dedicated to the maintenance of corporate aircraft. In 1982, K-C Aviation initiated shuttle flights for Kimberly-Clark employees between Appleton, Memphis, and Atlanta. With this experience, and considering the Airline Deregulation Act of 1978, Kimberly-Clark and K-C Aviation formed a regularly scheduled passenger airline, Midwest Express Airlines, which was started on June 11, 1984. The name of the airline was shortened to Midwest Airlines in 2003.
K-C Aviation divested itself from the airline in 1996. Two years later, Gulfstream Aerospace purchased K-C Aviation from Kimberly-Clark for $250 million, which included its operations at airports in Dallas, Appleton, and Westfield, Massachusetts.
Major product lines
Major American consumer product lines
Kimberly-Clark produces mostly paper-based consumer products. The company manufactures sanitary paper products and surgical & medical instruments. Kimberly-Clark brand name products include Kleenex facial tissue, Kotex feminine hygiene products, Cottonelle, Scott and Andrex toilet paper, Wypall utility wipes, KimWipes scientific cleaning wipes and Huggies disposable diapers and baby wipes.
Diapers and incontinence products
Huggies: diapers for infants and toddlers
Little Swimmers: swim diapers, marketed under the Huggies brand
Huggies Pull-Ups: training pants for toddlers undergoing toilet training, marketed under the Huggies brand
GoodNites (DryNites outside North America): pull-on diapers for children, teens and young adults who experience nocturnal enuresis (bedwetting), spun off from the Pull-Ups brand
Poise: Pads and liners for light to moderate urinary incontinence in adult women
Depend: diapers and briefs for adults
Feminine hygiene
Kotex
Kotex is a feminine hygiene product line that includes pantiliners, pads and tampons.
Tissues and wipes
Cottonelle
Cottonelle is a brand name for bath products. Product forms include premium bath tissue and flushable moist wipe products. In June 2019, the Federal Court of Australia found in favour of Kimberly-Clark Australia in Australian Competition & Consumer Commission's (ACCC) case against them for the claim that Kleenex Cottonelle Flushable Cleansing Cloths were advertised as "flushable" in Australia's sewerage system, in contrast to other similar products which warned consumers against flushing them.
The court said that although they contributed to household sewerage system blockages in an unknown number of instances, even faecal matter and toilet paper contributed to those problems. The ACCC argued unsuccessfully that Kimberly-Clark shouldn't be able to take advantage of the difficulty to isolate individual causes in individual cases, and that it was a significant cause of systematic issues. On October 13, 2020, the Cottonelle brand flushable wipes issued a recall because the products manufactured between February through September 2020 may contain Pluralibacter gergovaie.
Kleenex
Kleenex is a brand name of facial tissue paper. Many versions have been made, including "with lotion, our softest ever!" and "regular". In the 1970s, color psychologist Dr. Cody Sweet represented newly styled Kleenex boxes as a national media spokesperson.
Scott
Scott is a brand name of paper napkins, paper towels and bath tissue/wipes.
Viva
Viva is a brand name of heavy-duty paper towels.
Mexican consumer product lines
The Mexican market has most of the American products, as well as these products:
Napkins: Kleenex, Petalo, Suavel, Delsey, Lys.
Toilet paper: Kleenex, Petalo, Suavel, Delsey, Vogue, Lys.
Diapers: KleenBebe, a brand similar to Huggies. The name is a combination of "kleen" (Kleenex) and "bebe" (Spanish for "baby").
Professional and medical markets.
Major professional and global products
KimWipes
KimWipes are a type of cleaning tissue commonly used in laboratories. They are intended for applications in which leaving lint or fibers on a surface would be undesirable, such as on slides and pipettes. They are sometimes used to clean lenses, but use on optical lenses with special water- and solvent-based coatings may cause light blemishes, and the manufacturer recommends using a wipe specifically designed for use with coated lenses. KimWipes are composed of virgin wood pulp from certified forests, with few chemical additives.
WypAll
WypAll is a brand name for cleaning towels, wipes, and cloths. They are used in industrial settings and laboratories.
DryNites
DryNites are a version of GoodNites sold in Europe and Australasia.
Softex
Softex is a brand name for feminine hygiene and adult sanitary products sold in Indonesia.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
KMB Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
KMB Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos
| Data ex | Valor |
|---|---|
| 5 de Junho de 2026 | $1,2800 |
| 6 de Março de 2026 | $1,2800 |
| 5 de Dezembro de 2025 | $1,2600 |
| 5 de Setembro de 2025 | $1,2600 |
| 6 de Junho de 2025 | $1,2600 |
| 7 de Março de 2025 | $1,2600 |
| 6 de Dezembro de 2024 | $1,2200 |
| 6 de Setembro de 2024 | $1,2200 |
| 7 de Junho de 2024 | $1,2200 |
| 7 de Março de 2024 | $1,2200 |
| 7 de Dezembro de 2023 | $1,1800 |
| 7 de Setembro de 2023 | $1,1800 |
| 8 de Junho de 2023 | $1,1800 |
| 9 de Março de 2023 | $1,1800 |
| 8 de Dezembro de 2022 | $1,1600 |
| 8 de Setembro de 2022 | $1,1600 |
| 9 de Junho de 2022 | $1,1600 |
| 3 de Março de 2022 | $1,1600 |
| 9 de Dezembro de 2021 | $1,1400 |
| 9 de Setembro de 2021 | $1,1400 |
KMB Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
- Compra forte 4 19,0%
- Compra 5 23,8%
- Manter 11 52,4%
- Venda 0 0,0%
- Venda forte 1 4,8%
Preço-alvo de 12 meses
15 analistas · 2026-08-15Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $2.12 | $2.03 | 0.09% |
| 31 de Março de 2026 | $1.97 | $1.91 | 0.06% |
| 31 de Dezembro de 2025 | $1.86 | $1.83 | 0.03% |
| 30 de Setembro de 2025 | $1.82 | $1.77 | 0.05% |
| 30 de Junho de 2025 | $1.63 | $1.69 | -0.06% |
| 31 de Março de 2025 | $1.93 | $1.91 | 0.02% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| KMB | $33.49B | 16.6 | -2.1% | 12.3% | 172.6% | 36.0% |
| PG | $340.77B | 22.2 | 3.3% | 18.4% | 29.8% | — |
| CL | $63.31B | 30.0 | 1.4% | 10.5% | 1603.0% | 60.1% |
| CHD | — | 27.8 | 1.6% | 11.9% | 17.5% | 44.7% |
| CLX | $11.54B | 19.8 | -5.4% | 8.7% | 285.6% | 42.3% |
| REYN | $4.82B | 16.0 | 0.70% | 8.1% | 13.7% | 24.6% |
| WDFC | $2.93B | 32.4 | 5.0% | 14.7% | 35.7% | 55.1% |
| CENT | — | 13.0 | -2.2% | 5.2% | 10.5% | 31.9% |
| SPB | — | 13.6 | -5.2% | — | — | — |
| ENR | $1.70B | 7.5 | 2.3% | 8.1% | 157.3% | 41.8% |
| ODC | $1.12B | 23.1 | 11.0% | 11.1% | 21.8% | 29.5% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 16
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.45B | $16.80B | $17.15B | $20.18B | $19.44B | $19.14B | $18.45B | $18.49B | $18.35B | $18.29B | $18.59B | $19.72B | |
| Cost of Revenue | $10.52B | $10.52B | $10.88B | $13.96B | $13.45B | $12.32B | $12.41B | $12.89B | $11.76B | $11.60B | $11.97B | $13.04B | |
| Gross Profit | $5.92B | $6.29B | $6.27B | $6.22B | $5.99B | $6.82B | $6.04B | $5.60B | $6.59B | $6.69B | $6.62B | $6.68B | |
| R&D Expense | $326M | $328M | $303M | $292M | $269M | $276M | $284M | $317M | $309M | $326M | $324M | $368M | |
| Operating Income | $2.35B | $2.70B | $1.93B | $2.68B | $2.56B | $3.24B | $2.99B | $2.23B | $3.36B | $3.38B | $1.61B | $2.52B | |
| Interest Expense | $256M | $270M | $293M | $282M | $256M | $252M | $261M | $263M | $318M | $319M | $295M | $284M | |
| Interest Income | $24M | $48M | $66M | $14M | $6M | $8M | $11M | $10M | $10M | $11M | $17M | $18M | |
| Other Non-op | $-67M | $-60M | $-95M | $-73M | $-86M | $-70M | $-91M | $-163M | $-59M | $-66M | · | · | |
| Pretax Income | $2.05B | $2.42B | $1.61B | $2.34B | $2.23B | $2.93B | $2.65B | $1.81B | $2.99B | $3.01B | $1.33B | $2.25B | |
| Income Tax | $599M | $442M | $343M | $495M | $479M | $676M | $576M | $471M | $776M | $922M | $418M | $856M | |
| Net Income | $2.02B | $2.54B | $1.76B | $1.93B | $1.81B | $2.35B | $2.16B | $1.41B | $2.28B | $2.17B | $1.01B | $1.53B | |
| EPS (Basic) | $6.09 | $7.58 | $5.22 | $5.73 | $5.38 | $6.90 | $6.28 | $4.05 | $6.44 | $6.03 | $2.78 | $4.07 | |
| EPS (Diluted) | $6.07 | $7.55 | $5.21 | $5.72 | $5.35 | $6.87 | $6.24 | $4.03 | $6.40 | $5.99 | $2.77 | $4.04 | |
| Shares (Basic) | 331,900,000 | 335,600,000 | 337,800,000 | 337,400,000 | 337,300,000 | 340,700,000 | 343,600,000 | 348,000,000 | 353,600,000 | 359,400,000 | 363,800,000 | 374,500,000 | |
| Shares (Diluted) | 333,200,000 | 337,000,000 | 338,800,000 | 338,300,000 | 338,800,000 | 342,500,000 | 345,600,000 | 349,600,000 | 355,900,000 | 361,700,000 | 366,300,000 | 377,400,000 | |
| EBITDA | $3.16B | $3.99B | $3.10B | $3.44B | $3.33B | $4.04B | $3.91B | $3.11B | $4.02B | $4.02B | $1.61B | $2.52B |
Balanço Patrimonial 29
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $688M | $1.01B | $1.09B | $427M | $270M | $303M | $442M | $539M | $616M | $923M | $619M | $789M | |
| Receivables | $1.89B | $1.73B | $2.13B | $2.28B | $2.21B | $2.23B | $2.26B | $2.16B | $2.31B | $2.18B | $2.28B | $2.22B | |
| Inventory | $1.48B | $1.45B | $1.96B | $2.27B | $2.24B | $1.90B | $1.79B | $1.81B | $1.79B | $1.68B | $1.91B | $1.89B | |
| Prepaid Expense | $304M | $292M | $252M | · | · | · | · | · | · | · | · | · | |
| Other Current Assets | $535M | $694M | $520M | $753M | $849M | $733M | $562M | $525M | $490M | $337M | $617M | $655M | |
| Current Assets | $5.31B | $5.58B | $5.70B | $5.73B | $5.57B | $5.17B | $5.06B | $5.04B | $5.21B | $5.12B | $5.43B | $5.56B | |
| PP&E (Net) | $6.78B | $6.28B | $7.91B | $7.88B | $8.10B | $8.04B | $7.45B | $7.16B | $7.44B | $7.17B | $7.10B | $7.36B | |
| PP&E (Gross) | $16.51B | $15.70B | $19.15B | $18.55B | $18.53B | $18.33B | $17.84B | $17.71B | $17.91B | $16.85B | $16.55B | $16.78B | |
| Accum. Depreciation | $9.73B | $9.42B | $11.24B | $10.66B | $10.43B | $10.29B | $10.39B | $10.55B | $10.48B | $9.69B | $9.44B | $9.42B | |
| Goodwill | $1.84B | $1.80B | $1.89B | $2.07B | $1.84B | $1.90B | $1.47B | $1.47B | $1.58B | $1.48B | $1.45B | $1.63B | |
| Intangibles | $77M | $80M | $197M | $851M | $810M | $832M | $29M | · | · | · | · | $109M | |
| Other Non-current Assets | $1.06B | $984M | $1.14B | $1.19B | $1.24B | $1.28B | $1.01B | $620M | $695M | $581M | $619M | $723M | |
| Total Assets | $17.10B | $16.55B | $17.34B | $17.97B | $17.84B | $17.52B | $15.28B | $14.52B | $15.15B | $14.60B | $14.84B | $15.53B | |
| Accounts Payable | $3.39B | $3.26B | $3.65B | $3.81B | $3.84B | $3.34B | $3.06B | $3.19B | $2.83B | $2.61B | $2.61B | $2.62B | |
| Accrued Liabilities | $1.89B | $2.09B | $2.32B | $2.29B | $2.10B | $2.26B | $1.98B | $1.79B | $1.73B | $1.77B | $1.75B | $1.97B | |
| Current Liabilities | $7.12B | $7.00B | $6.93B | $7.33B | $6.75B | $6.44B | $6.92B | $6.54B | $5.86B | $5.85B | $6.35B | $6.23B | |
| Capital Leases | $258M | $265M | $346M | · | · | · | $274M | · | · | · | · | · | |
| Deferred Tax | $445M | $300M | $374M | $647M | $694M | $723M | $511M | $458M | $395M | $532M | $766M | $587M | |
| Other Non-current Liabilities | $646M | $609M | $860M | $799M | $681M | $718M | $520M | $328M | $299M | $309M | $380M | $319M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | $7.40B | $6.70B | $6.18B | |
| Total Debt | · | · | · | · | · | · | · | · | · | $7.40B | $6.70B | $6.18B | |
| Common Stock | $473M | $473M | $473M | $473M | $473M | $473M | $473M | $473M | $473M | $473M | $473M | $536M | |
| Paid-in Capital | $849M | $862M | $878M | $679M | $605M | $657M | $556M | $548M | $594M | $697M | $609M | $632M | |
| Retained Earnings | $9.61B | $9.26B | $8.37B | $8.20B | $7.86B | $7.57B | $6.69B | $5.95B | $5.77B | $5.83B | $4.99B | $8.47B | |
| Treasury Stock | $5.99B | $5.99B | $5.22B | $5.14B | $5.18B | $4.90B | $4.45B | $3.96B | $3.29B | $3.63B | $2.97B | $5.60B | |
| AOCI | $-3.44B | $-3.77B | $-3.58B | $-3.67B | $-3.24B | $-3.17B | $-3.29B | $-3.30B | $-2.92B | $-3.47B | $-3.28B | $-3.31B | |
| Stockholders' Equity | $1.50B | $840M | $915M | $547M | $514M | $626M | $-33M | $-287M | $882M | $-102M | $-174M | $729M | |
| Liabilities + Equity | $17.10B | $16.55B | $17.34B | $17.97B | $17.84B | $17.52B | $15.28B | $14.52B | $15.15B | $14.60B | $14.84B | $15.53B | |
| Shares Outstanding | 331,900,000 | 331,800,000 | 337,000,000 | 337,500,000 | 336,800,000 | 338,700,000 | 341,400,000 | 345,000,000 | 351,100,000 | 356,600,000 | 360,900,000 | 365,300,000 |
Fluxo de Caixa 18
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $805M | $781M | $753M | $754M | $766M | $796M | $917M | $882M | $724M | $705M | $746M | $862M | |
| Stock-based Comp | $140M | $131M | $169M | $150M | $26M | $147M | $96M | $41M | $76M | $77M | $75M | $52M | |
| Deferred Tax | $241M | $-38M | $-322M | $-57M | $-70M | $45M | $29M | $2M | $-69M | $-15M | $-255M | $63M | |
| Amort. of Intangibles | $2M | $7M | $11M | $15M | $9M | $2M | $3M | · | · | · | · | · | |
| Other Non-cash | $-933M | $-7M | $1.76B | $-65M | $240M | $752M | $-751M | $1.02B | $-228M | $633M | · | · | |
| Operating Cash Flow | $2.78B | $3.23B | $3.54B | $2.73B | $2.73B | $3.73B | $2.74B | $2.97B | $2.93B | $3.23B | $2.31B | $2.85B | |
| CapEx | $1.14B | $721M | $766M | $876M | $1.01B | $1.22B | $1.21B | $877M | $785M | $771M | $1.06B | $1.04B | |
| Investing Cash Flow | $-951M | $-100M | $-418M | $-785M | $-1.06B | $-2.31B | $-1.04B | $-902M | $-851M | $-732M | $-1.05B | · | |
| Debt Issued | $0 | $0 | $363M | $0 | $605M | $1.84B | $706M | $507M | $937M | $1.29B | $1.10B | $1.26B | |
| Net Debt Issued | $-550M | $-554M | $-112M | $-312M | $336M | $991M | $-1M | $100M | $-544M | $695M | $547M | $1.13B | |
| Stock Repurchased | $141M | $1.00B | $225M | $100M | $400M | $700M | $800M | $800M | $911M | $739M | $861M | $1.94B | |
| Net Stock Activity | $-141M | $-1.00B | $-225M | $-100M | $-400M | $-700M | $-800M | $-800M | $-911M | $-739M | $-861M | $-1.94B | |
| Dividends Paid | $1.66B | $1.63B | $1.59B | $1.56B | $1.52B | $1.45B | $1.41B | $1.39B | $1.36B | $1.31B | $1.27B | $1.26B | |
| Financing Cash Flow | $-2.18B | $-3.17B | $-2.37B | $-1.76B | $-1.70B | $-1.57B | $-1.79B | $-2.12B | $-2.42B | $-2.19B | $-1.30B | · | |
| Net Change in Cash | $-320M | $-72M | $666M | $157M | $-33M | $-139M | $-97M | $-77M | $-307M | $304M | $-170M | $-265M | |
| Taxes Paid | $497M | $587M | $648M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.64B | $2.51B | $2.78B | $1.86B | $1.72B | $2.51B | $1.53B | $2.09B | $2.14B | $2.46B | $1.25B | $1.81B | |
| Levered FCF | $1.46B | $2.30B | $2.55B | $1.63B | $1.52B | $2.32B | $1.32B | $1.90B | $1.91B | $2.24B | $1.05B | $1.63B |
Lucratividade 8
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 36.0% | 35.8% | 34.4% | 30.8% | 30.8% | 35.6% | 32.7% | 30.3% | 35.9% | 36.5% | 35.6% | 33.9% | |
| Operating Margin | 14.3% | 16.0% | 11.5% | 13.3% | 13.2% | 17.0% | 16.2% | 12.1% | 18.1% | 18.2% | 8.7% | 12.8% | |
| Net Margin | 12.3% | 12.7% | 8.6% | 9.6% | 9.3% | 12.3% | 11.7% | 7.6% | 12.5% | 11.9% | 5.5% | 7.7% | |
| Pretax Margin | 12.5% | 14.6% | 9.9% | 11.6% | 11.5% | 15.3% | 14.4% | 9.8% | 16.4% | 16.5% | 7.2% | 11.4% | |
| EBITDA Margin | 19.2% | 19.9% | 15.2% | 17.0% | 17.1% | 21.1% | 21.2% | 16.8% | 22.0% | 22.1% | 8.7% | 12.8% | |
| ROA | 12.0% | 15.0% | 10.0% | 10.8% | 10.3% | 14.3% | 14.5% | 9.5% | 15.3% | 14.7% | 6.7% | 8.9% | |
| ROE | 172.6% | 290.0% | 241.3% | 364.6% | 297.1% | 391.0% | 7843.6% | -1611.4% | 864.5% | -1569.6% | 365.1% | 54.6% | |
| ROIC | 110.8% | 308.4% | 198.8% | 386.4% | 391.0% | 398.6% | -7093.6% | -574.9% | 388.4% | 31.5% | 17.0% | 22.6% |
Liquidez e Solvência 5
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 | 0.9 | 0.9 | 0.9 | 0.9 | |
| Quick Ratio | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | -72.6 | -38.5 | 8.5 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | -63.1 | -35.1 | 7.7 | |
| Interest Coverage | 9.2 | 11.9 | 8.0 | 9.5 | 10.0 | 12.9 | 11.5 | 8.5 | 10.4 | 10.4 | 5.5 | 8.9 |
Eficiência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 1.2 | 1.2 | 1.1 | 1.1 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.1 | |
| Inventory Turnover | 7.2 | 6.8 | 6.3 | 6.2 | 6.5 | 6.7 | 6.9 | 7.2 | 6.7 | 6.4 | 6.3 | 6.3 | |
| Receivables Turnover | 9.1 | 9.7 | 9.3 | 9.0 | 8.8 | 8.5 | 8.3 | 8.3 | 8.1 | 8.2 | 8.3 | 8.3 |
Taxas de Crescimento 10
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -2.1% | -2.0% | -15.0% | 3.8% | 1.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -6.6% | -4.7% | -3.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -3.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -19.6% | 44.9% | -8.9% | 6.9% | -22.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 2.0% | 12.2% | -8.8% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -2.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -20.6% | 44.3% | -8.8% | 6.6% | -22.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 1.5% | 11.9% | -9.1% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -3.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 2.7% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 16
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $16.45B | $16.80B | $17.15B | $20.18B | $19.44B | $19.14B | $18.45B | $18.49B | $18.35B | $18.29B | $18.59B | $19.72B | |
| Net Income TTM | $2.02B | $2.54B | $1.76B | $1.93B | $1.81B | $2.35B | $2.16B | $1.41B | $2.28B | $2.17B | $1.01B | $1.53B | |
| Market Cap | $33.49B | $43.48B | $40.95B | $45.82B | $48.14B | $45.67B | $46.96B | $39.31B | $42.36B | $40.70B | $45.94B | $42.21B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | $47.17B | $52.03B | $47.60B | |
| P/E | 16.6 | 17.4 | 23.3 | 23.7 | 26.7 | 19.6 | 22.0 | 28.3 | 18.9 | 19.1 | 46.0 | 28.6 | |
| P/S | 2.0 | 2.6 | 2.4 | 2.3 | 2.5 | 2.4 | 2.5 | 2.1 | 2.3 | 2.2 | 2.5 | 2.1 | |
| P/B | 22.3 | 51.8 | 44.8 | 83.8 | 93.6 | 73.0 | -1423.0 | -137.0 | 67.4 | -399.0 | -264.0 | 57.9 | |
| P / Cash Flow | 12.1 | 13.4 | 11.6 | 16.8 | 17.6 | 12.2 | 17.2 | 13.2 | 14.5 | 12.6 | 19.9 | 14.8 | |
| P / FCF | 20.4 | 17.3 | 14.8 | 24.7 | 27.9 | 18.2 | 30.8 | 18.8 | 19.8 | 16.5 | 36.8 | 23.4 | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | 11.7 | 32.3 | 18.9 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | 19.2 | 41.6 | 26.4 | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | 2.6 | 2.8 | 2.4 | |
| Dividend Yield | 5.0% | 3.7% | 3.9% | 3.4% | 3.1% | 3.2% | 3.0% | 3.5% | 3.2% | 3.2% | 2.8% | 3.0% | |
| Earnings Yield | 6.0% | 5.8% | 4.3% | 4.2% | 3.7% | 5.1% | 4.5% | 3.5% | 5.3% | 5.2% | 2.2% | 3.5% | |
| Payout Ratio | 82.1% | 64.0% | 90.0% | 80.6% | 83.6% | 61.7% | 65.3% | 98.3% | 59.7% | 60.5% | 125.6% | 82.3% | |
| Annual Payout | $1.66B | $1.63B | $1.59B | $1.56B | $1.52B | $1.45B | $1.41B | $1.39B | $1.36B | $1.31B | $1.27B | $1.26B |
Demonstração de Resultados 15
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.19B | $4.16B | $4.08B | $4.15B | $4.16B | $4.05B | $4.10B | $4.14B | $4.23B | $4.33B | $1.69B | $5.13B | $5.13B | $5.20B | $4.96B | $5.05B | |
| Cost of Revenue | $2.59B | $2.63B | $2.05B | $2.66B | $2.71B | $2.54B | $2.06B | $2.58B | $2.64B | $3.24B | $711M | $3.29B | $3.40B | $3.47B | $3.34B | $3.51B | |
| Gross Profit | $1.60B | $1.53B | $1.47B | $1.49B | $1.46B | $1.51B | $1.45B | $1.56B | $1.59B | $1.69B | $974M | $1.84B | $1.73B | $1.73B | $1.63B | $1.54B | |
| Operating Income | $633M | $753M | $369M | $621M | $592M | $631M | $282M | $1.03B | $539M | $853M | $254M | $774M | $113M | $787M | $712M | $655M | |
| Interest Expense | $53M | $58M | $60M | $65M | $67M | $64M | $64M | $67M | $72M | $67M | $70M | $74M | $76M | $73M | $76M | $73M | |
| Interest Income | $4M | $5M | $6M | $6M | $5M | $7M | $11M | $18M | $9M | $10M | $32M | $18M | $9M | $7M | $7M | $4M | |
| Other Non-op | $-12M | $-15M | $-16M | $-16M | $-17M | $-17M | $-15M | $-15M | $-15M | $-15M | $-17M | $-20M | $-42M | $-16M | $-24M | $-18M | |
| Pretax Income | $572M | $685M | $436M | $546M | $513M | $557M | $352M | $962M | $461M | · | · | · | · | · | · | · | |
| Income Tax | $217M | $164M | $70M | $248M | $116M | $131M | $11M | $187M | $60M | $184M | $45M | $157M | $-32M | $173M | $139M | $127M | |
| Net Income | $345M | $665M | $499M | $446M | $509M | $567M | $447M | $907M | $544M | $647M | $509M | $587M | $102M | $566M | $507M | $467M | |
| EPS (Basic) | $1.04 | $2.00 | $1.50 | $1.34 | $1.53 | $1.71 | $1.34 | $2.70 | $1.61 | $1.92 | $1.50 | $1.74 | $0.30 | $1.68 | $1.50 | $1.38 | |
| EPS (Diluted) | $1.04 | $2.00 | $1.50 | $1.34 | $1.53 | $1.70 | $1.34 | $2.69 | $1.61 | $1.91 | $1.51 | $1.73 | $0.30 | $1.67 | $1.50 | $1.38 | |
| Shares (Basic) | 332,400,000 | 331,900,000 | -663,800,000 | 331,800,000 | 332,100,000 | 331,800,000 | -674,100,000 | 335,700,000 | 337,100,000 | 336,900,000 | -675,800,000 | 338,100,000 | 338,000,000 | 337,500,000 | -674,600,000 | 337,600,000 | |
| Shares (Diluted) | 333,300,000 | 333,200,000 | -666,500,000 | 333,100,000 | 333,300,000 | 333,300,000 | -676,500,000 | 337,200,000 | 338,000,000 | 338,300,000 | -677,600,000 | 338,900,000 | 338,900,000 | 338,600,000 | -676,500,000 | 338,300,000 | |
| EBITDA | $633M | $946M | · | $621M | $592M | $987M | · | $1.15B | $655M | $1.04B | · | $774M | $113M | $975M | · | $655M |
Balanço Patrimonial 27
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $956M | $542M | $688M | $617M | $634M | $563M | $1.01B | $1.11B | $1.16B | $853M | · | $814M | $580M | $524M | · | $362M | |
| Receivables | $1.86B | $2.00B | $1.89B | $1.97B | $2.01B | $2.18B | $1.73B | $2.23B | $2.31B | $2.38B | · | $2.30B | $2.36B | $2.43B | · | $2.33B | |
| Inventory | $1.54B | $1.48B | $1.48B | $1.54B | $1.56B | $1.91B | $1.45B | $1.94B | $1.92B | $1.88B | · | $2.02B | $2.13B | $2.22B | · | $2.28B | |
| Prepaid Expense | · | · | $304M | · | · | · | $292M | · | · | · | · | · | · | · | · | · | |
| Other Current Assets | $636M | $547M | $535M | $570M | $572M | $633M | $694M | $570M | $565M | $487M | · | $594M | $677M | $673M | · | $649M | |
| Current Assets | $6.35B | $5.29B | $5.31B | $5.47B | $5.56B | $5.28B | $5.58B | $5.85B | $5.95B | $5.60B | · | $5.73B | $5.74B | $5.85B | · | $5.62B | |
| PP&E (Net) | $6.95B | $6.83B | $6.78B | $6.53B | $6.32B | $7.51B | $6.28B | $7.70B | $7.62B | $7.77B | · | $7.70B | $7.82B | $7.87B | · | $7.74B | |
| PP&E (Gross) | $16.84B | $16.69B | $16.51B | $16.36B | $16.08B | $19.17B | $15.70B | $19.32B | $18.98B | $19.06B | · | $18.65B | $18.72B | $18.70B | · | $18.14B | |
| Accum. Depreciation | $9.89B | $9.86B | $9.73B | $9.83B | $9.76B | $11.66B | $9.42B | $11.62B | $11.36B | $11.29B | · | $10.95B | $10.91B | $10.83B | · | $10.41B | |
| Goodwill | $1.83B | $1.84B | $1.84B | $1.83B | $1.84B | $1.97B | $1.80B | $2.06B | $2.02B | $2.04B | $1.89B | $2.04B | $2.09B | $2.09B | $2.07B | $2.04B | |
| Intangibles | $73M | $76M | $77M | · | · | · | $80M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $1.04B | $1.06B | $1.06B | $996M | $1.00B | $1.11B | $984M | $1.10B | $1.13B | $1.12B | · | $1.16B | $1.23B | $1.22B | · | $1.30B | |
| Total Assets | $18.55B | $17.18B | $17.10B | $16.89B | $16.77B | $16.30B | $16.55B | $17.16B | $17.28B | $17.09B | · | $17.15B | $17.38B | $18.18B | · | $17.84B | |
| Accounts Payable | $3.37B | $3.25B | $3.39B | $3.23B | $3.25B | $3.60B | $3.26B | $3.64B | $3.61B | $3.53B | · | $3.49B | $3.71B | $3.79B | · | $3.66B | |
| Accrued Liabilities | $2.27B | $1.90B | $1.89B | $1.87B | $2.02B | $2.14B | $2.09B | $2.45B | $2.18B | $2.13B | · | $2.26B | $2.30B | $2.38B | · | $2.19B | |
| Current Liabilities | $6.99B | $6.90B | $7.12B | $7.08B | $7.17B | $6.92B | $7.00B | $7.07B | $7.01B | $6.88B | · | $6.83B | $6.60B | $7.09B | · | $7.20B | |
| Capital Leases | · | · | $258M | · | · | · | $265M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $473M | $500M | $445M | $413M | $243M | $319M | $300M | $355M | $380M | $395M | · | $404M | $490M | $612M | · | $636M | |
| Other Non-current Liabilities | $622M | $623M | $646M | $653M | $680M | $683M | $609M | $751M | $784M | $796M | · | $809M | $848M | $810M | · | $695M | |
| Common Stock | $473M | $473M | $473M | $473M | $473M | $473M | $473M | $473M | $473M | $473M | · | $473M | $473M | $473M | $473M | $473M | |
| Paid-in Capital | $788M | $867M | $849M | $829M | $798M | $842M | $862M | $844M | $802M | $877M | · | $761M | $697M | $694M | · | $633M | |
| Retained Earnings | $9.77B | $9.85B | $9.61B | $9.52B | $9.49B | $9.41B | $9.26B | $9.28B | $8.73B | $8.60B | · | $8.22B | $8.04B | $8.37B | · | $8.09B | |
| Treasury Stock | $5.89B | $5.98B | $5.99B | $5.99B | $5.99B | $5.99B | $5.99B | $5.75B | $5.24B | $5.25B | · | $5.10B | $5.07B | $5.15B | · | $5.13B | |
| AOCI | $-3.39B | $-3.41B | $-3.44B | $-3.50B | $-3.51B | $-3.63B | $-3.77B | $-3.56B | $-3.63B | $-3.65B | · | $-3.67B | $-3.64B | $-3.66B | · | $-3.63B | |
| Stockholders' Equity | $1.75B | $1.80B | $1.50B | $1.33B | $1.27B | $1.10B | $840M | $1.28B | $1.14B | $1.04B | · | $680M | $500M | $719M | · | $437M | |
| Liabilities + Equity | $18.55B | $17.18B | $17.10B | $16.89B | $16.77B | $16.30B | $16.55B | $17.16B | $17.28B | $17.09B | · | $17.15B | $17.38B | $18.18B | · | $17.84B | |
| Shares Outstanding | 332,600,000 | 331,900,000 | 331,900,000 | 331,900,000 | 331,900,000 | 331,900,000 | 331,800,000 | 333,500,000 | 337,000,000 | 336,800,000 | 337,000,000 | 338,000,000 | 338,200,000 | 337,400,000 | 337,500,000 | 337,500,000 |
Fluxo de Caixa 16
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $167M | $193M | $189M | $176M | $222M | $218M | $217M | $191M | $188M | $185M | $187M | $189M | $189M | $188M | $186M | $188M | |
| Stock-based Comp | $41M | $23M | $25M | $42M | $41M | $32M | $21M | $39M | $39M | $32M | $38M | $60M | $47M | $24M | $49M | $33M | |
| Deferred Tax | $-119M | $36M | $37M | $234M | $-37M | $7M | $48M | $-7M | $-68M | $-11M | $-25M | $-59M | $-188M | $-50M | $74M | $-96M | |
| Other Non-cash | · | $-288M | · | · | · | $-973M | · | · | · | $-782M | · | · | · | $-200M | · | · | |
| Operating Cash Flow | $908M | $745M | $972M | $708M | $770M | $327M | $817M | $958M | $1.02B | $438M | $1.22B | $927M | $787M | $613M | $991M | $798M | |
| CapEx | $352M | $424M | $397M | $340M | $197M | $204M | $209M | $160M | $158M | $194M | $217M | $160M | $188M | $201M | $197M | $209M | |
| Investing Cash Flow | $-410M | $-355M | $-301M | $-338M | $-193M | $-119M | $-194M | $470M | $-195M | $-181M | $-152M | $-191M | $40M | $-115M | $-268M | $-240M | |
| Debt Issued | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $6M | $0 | $9M | $348M | $0 | $0 | |
| Net Debt Issued | · | $-400M | · | · | · | $-250M | · | · | · | $0 | · | · | · | $348M | · | · | |
| Stock Repurchased | $0 | $0 | $1M | $20M | $59M | $61M | $248M | $596M | $102M | $54M | $130M | $32M | $33M | $30M | $26M | $25M | |
| Net Stock Activity | · | $0 | · | · | · | $-61M | · | · | · | $-54M | · | · | · | $-30M | · | · | |
| Dividends Paid | $425M | $418M | $418M | $418M | $419M | $405M | $408M | $411M | $411M | $398M | $399M | $399M | $399M | $391M | $391M | $392M | |
| Financing Cash Flow | $305M | $-527M | $-608M | $-388M | $-500M | $-683M | $-686M | $-1.48B | $-513M | $-485M | $-754M | $-468M | $-755M | $-397M | $-651M | $-489M | |
| Net Change in Cash | $804M | $-142M | $67M | $-23M | $94M | $-458M | $-90M | $-52M | $310M | $-240M | $279M | $234M | $56M | $97M | $65M | $51M | |
| Free Cash Flow | · | $321M | · | · | · | $123M | · | · | · | $244M | · | · | · | $412M | · | · | |
| Levered FCF | · | $277M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Lucratividade 8
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.3% | 36.9% | · | 36.0% | 35.0% | 35.8% | · | 36.0% | 36.0% | 37.1% | · | 35.8% | 33.7% | 33.2% | · | 30.5% | |
| Operating Margin | 15.1% | 18.1% | · | 15.0% | 14.2% | 15.9% | · | 23.3% | 13.0% | 16.6% | · | 15.1% | 2.2% | 15.2% | · | 13.0% | |
| Net Margin | 8.2% | 16.0% | · | 10.8% | 12.2% | 11.7% | · | 18.3% | 10.8% | 12.6% | · | 11.4% | 2.0% | 10.9% | · | 9.2% | |
| Pretax Margin | 13.7% | 16.4% | · | 13.2% | 12.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | 15.1% | 22.7% | · | 15.0% | 14.2% | 20.4% | · | 23.3% | 13.0% | 20.2% | · | 15.1% | 2.2% | 18.8% | · | 13.0% | |
| ROA | 1.9% | 4.0% | · | 2.6% | 3.0% | 3.4% | · | 5.3% | 3.1% | 3.7% | · | 3.4% | 0.57% | 3.1% | · | 2.6% | |
| ROE | 22.8% | 45.9% | · | 34.1% | 42.3% | 52.9% | · | 92.3% | 66.5% | 73.4% | · | 105.1% | 18.7% | 79.5% | · | 102.5% | |
| ROIC | 22.4% | 31.9% | · | 25.4% | 36.0% | · | · | · | · | · | · | · | · | · | · | · |
Liquidez e Solvência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | 0.9 | 0.8 | · | 0.8 | |
| Quick Ratio | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.4 | 0.4 | · | 0.4 | |
| Interest Coverage | 11.9 | 13.0 | · | 9.6 | 8.8 | 12.0 | · | 17.2 | 9.1 | 12.7 | · | 10.5 | 1.5 | 10.8 | · | 9.0 |
Eficiência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 1.7 | 1.6 | · | 1.5 | 1.6 | 1.6 | · | 1.6 | 1.6 | 1.6 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | |
| Receivables Turnover | 2.2 | 2.0 | · | 2.0 | 1.9 | 2.1 | · | 2.2 | 2.2 | 2.1 | · | 2.2 | 2.1 | 2.1 | · | 2.1 |
Avaliação (TTM) 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $16.58B | $16.56B | · | $16.47B | $16.46B | $16.53B | · | $17.83B | $18.82B | $19.79B | · | $20.51B | $20.45B | $20.41B | · | $20.22B | |
| Net Income TTM | $1.96B | $2.12B | · | $1.97B | $2.43B | $2.46B | · | $2.69B | $1.88B | $1.90B | · | $1.72B | $1.57B | $1.99B | · | $1.90B | |
| Market Cap | $36.51B | $32.02B | · | $41.27B | $42.79B | $47.20B | · | $47.45B | $46.57B | $43.57B | · | $40.85B | $46.69B | $45.29B | · | $37.98B | |
| P/E | 18.7 | 15.1 | · | 21.0 | 17.8 | 19.4 | · | 17.9 | 24.9 | 23.1 | · | 23.8 | 29.8 | 22.8 | · | 20.1 | |
| P/S | 2.2 | 1.9 | · | 2.5 | 2.6 | 2.9 | · | 2.7 | 2.5 | 2.2 | · | 2.0 | 2.3 | 2.2 | · | 1.9 | |
| P/B | 20.9 | 17.8 | · | 31.0 | 33.7 | 42.9 | · | 36.9 | 41.0 | 41.7 | · | 60.1 | 93.4 | 63.0 | · | 86.9 | |
| P / Cash Flow | · | 43.0 | · | · | · | 144.4 | · | · | · | 99.5 | · | · | · | 73.9 | · | · | |
| P / FCF | · | 99.7 | · | · | · | 383.8 | · | · | · | 178.5 | · | · | · | 109.9 | · | · | |
| Earnings Yield | 5.4% | 6.6% | · | 4.8% | 5.6% | 5.2% | · | 5.6% | 4.0% | 4.3% | · | 4.2% | 3.4% | 4.4% | · | 5.0% | |
| Payout Ratio | · | 62.9% | · | · | · | 71.4% | · | · | · | 61.5% | · | · | · | 69.1% | · | · |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $16.45B | $16.80B | $17.15B | $20.18B | $19.44B |
| Margem Bruta % | 36.0% | 35.8% | 34.4% | 30.8% | 30.8% |
| Margem Operacional % | 14.3% | 16.0% | 11.5% | 13.3% | 13.2% |
| Lucro líquido | $2.02B | $2.54B | $1.76B | $1.93B | $1.81B |
| EPS Diluído | $6.07 | $7.55 | $5.21 | $5.72 | $5.35 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 0.7 | 0.8 | 0.8 | 0.8 | 0.8 |
| Índice de Liquidez Seca | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $1.64B | $2.51B | $2.78B | $1.86B | $1.72B |
Últimas notícias Notícias recentes mencionando esta empresa
- Jim Cramer: Aquisição da Kenvue pela Kimberly-Clark Cria Potência de Alta Margem
- Kimberly-Clark vs. The Clorox: Qual ação de bens de consumo é melhor comprar em 2026?
- Atualização do Mercado: CVS, ETN, KMB, KO, PSX
- SDY, O, KVUE, KMB: Grandes Saídas Detectadas no ETF
- Kimberly-Clark Reafirma a Perspectiva de 2026 - Atualização
- Kimberly-Clark Corp Anuncia Aumento No Lucro Do 1º Trimestre
- Jim Cramer Diz "Eu Acho que a 5,25% de Rendimento, Eu Quero Possuir Kimberly-Clark (KMB)"
- Trabalhador que disse que não era pago o suficiente para viver acusado de incendiar armazém da Kimberly-Clark que serve 50 milhões
- "Adeus ao Seu Estoque": Funcionário Insatisfeito Incêndia Armazém de Papel Higiênico de Milhão de Pés Quadrados
- Prudential Financial Agora a #274ª Maior Empresa, Superando a Kimberly-Clark
Sinais de trading Sinais recentes de compra/venda com preço de entrada e relação risco/recompensa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 1.875 declarantes · $21.9B total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 191 (-16 vs trimestre anterior) | 108 (-80 vs trimestre anterior) | 613 (+1 vs trimestre anterior) | 615 (+36 vs trimestre anterior) | +4.5M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $2.377.804.260 | 21.661.695 | 10,84% | Ações |
| STATE STREET CORP | $2.340.807.955 | 21.081.552 | 10,67% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.767.258.471 | 16.099.649 | 8,06% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $1.106.986.005 | 10.119.883 | 5,05% | Ações |
| TWO SIGMA INVESTMENTS, LP | $774.386.955 | 7.054.632 | 3,53% | Ações |
| FMR LLC | $760.628.265 | 6.929.291 | 3,47% | Ações |
| WELLINGTON MANAGEMENT GROUP LLP | $692.422.574 | 6.307.940 | 3,16% | Ações |
| NORGES BANK | $633.769.938 | 5.773.617 | 2,89% | Ações |
| THORNBURG INVESTMENT MANAGEMENT INC | $632.372.676 | 5.760.888 | 2,88% | Ações |
| AMERICAN CENTURY COMPANIES INC | $615.581.910 | 5.607.923 | 2,81% | Ações |
| Sessa Capital IM, L.P. | $572.125.082 | 5.212.035 | 2,61% | Ações |
| TWO SIGMA ADVISERS, LP | $246.383.469 | 2.442.100 | 1,12% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $237.487.517 | 2.163.501 | 1,08% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $206.144.767 | 1.877.970 | 0,94% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $190.132.617 | 1.732.100 | 0,87% | Opção de compra |
| ProShare Advisors LLC | $189.198.364 | 1.723.589 | 0,86% | Ações |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $188.902.205 | 1.720.891 | 0,86% | Ações |
| Capital Research Global Investors | $175.673.748 | 1.600.380 | 0,80% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $164.611.092 | 1.499.600 | 0,75% | Ações |
| NORDEA INVESTMENT MANAGEMENT AB | $158.346.695 | 1.455.660 | 0,72% | Ações |
| FIRST TRUST ADVISORS LP | $145.368.483 | 1.324.301 | 0,66% | Ações |
| LPL Financial LLC | $135.068.228 | 1.230.466 | 0,62% | Ações |
| BANK OF AMERICA CORP /DE/ | $129.861.313 | 1.183.031 | 0,59% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $121.526.367 | 1.107.100 | 0,55% | Opção de venda |
| RAYMOND JAMES FINANCIAL INC | $121.185.775 | 1.103.997 | 0,55% | Ações |
| GOLDMAN SACHS GROUP INC | $115.678.403 | 1.053.825 | 0,53% | Ações |
| FRANKLIN RESOURCES INC | $112.472.279 | 1.024.431 | 0,51% | Ações |
| Squarepoint Ops LLC | $107.951.111 | 983.430 | 0,49% | Ações |
| FEDERATED HERMES, INC. | $104.141.324 | 948.723 | 0,47% | Ações |
| Swiss National Bank | $102.777.651 | 936.300 | 0,47% | Ações |
| JANE STREET GROUP, LLC | $100.285.872 | 913.600 | 0,46% | Opção de compra |
| ENVESTNET ASSET MANAGEMENT INC | $99.106.078 | 902.852 | 0,45% | Ações |
| Mitsubishi UFJ Asset Management Co., Ltd. | $94.857.546 | 864.144 | 0,43% | Ações |
| Brandywine Global Investment Management, LLC | $93.022.053 | 922.106 | 0,42% | Ações |
| Sumitomo Mitsui Trust Group, Inc. | $84.463.954 | 769.463 | 0,39% | Ações |
| VANGUARD ASSET MANAGEMENT, Ltd | $79.926.281 | 728.125 | 0,36% | Ações |
| Vanguard Global Advisers, LLC | $78.644.717 | 716.450 | 0,36% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $78.290.159 | 713.220 | 0,36% | Ações |
| Sarasin & Partners LLP | $76.804.860 | 699.689 | 0,35% | Ações |
| National Pension Service | $75.917.591 | 691.606 | 0,35% | Ações |
| UBS Group AG | $75.378.181 | 686.692 | 0,34% | Ações |
| Legal & General Group Plc | $71.976.077 | 655.699 | 0,33% | Ações |
| RHUMBLINE ADVISERS | $69.927.640 | 637.039 | 0,32% | Ações |
| BARCLAYS PLC | $67.205.584 | 612.240 | 0,31% | Ações |
| BlackRock, Inc. | $66.070.014 | 601.895 | 0,30% | Ações |
| VICTORY CAPITAL MANAGEMENT INC | $65.718.860 | 598.696 | 0,30% | Ações |
| NewEdge Advisors, LLC | $65.364.102 | 595.464 | 0,30% | Ações |
| Empower Advisory Group, LLC | $62.385.334 | 568.328 | 0,28% | Ações |
| VANGUARD GROUP INC | $62.209.480 | 616.607 | 0,28% | Ações |
| NOMURA ASSET MANAGEMENT CO LTD | $59.274.263 | 539.986 | 0,27% | Ações |
| DONALDSON CAPITAL MANAGEMENT, LLC | $58.665.360 | 534.439 | 0,27% | Ações |
| CITADEL ADVISORS LLC | $58.617.180 | 534.000 | 0,27% | Opção de compra |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $57.275.253 | 567.700 | 0,26% | Ações |
| D. E. Shaw & Co., Inc. | $54.543.396 | 496.888 | 0,25% | Ações |
| Vest Financial, LLC | $54.395.645 | 495.542 | 0,25% | Ações |
| Pictet Asset Management Holding SA | $52.833.838 | 481.314 | 0,24% | Ações |
| Welch Group, LLC | $50.688.581 | 461.771 | 0,23% | Ações |
| CITADEL ADVISORS LLC | $50.647.878 | 461.400 | 0,23% | Opção de venda |
| KING LUTHER CAPITAL MANAGEMENT CORP | $49.046.663 | 446.813 | 0,22% | Ações |
| LEVIN CAPITAL STRATEGIES, L.P. | $48.036.872 | 437.614 | 0,22% | Ações |
| WELLS FARGO & COMPANY/MN | $47.310.870 | 431.000 | 0,22% | Opção de venda |
| Associated Banc-Corp | $47.232.603 | 430.287 | 0,22% | Ações |
| JONES FINANCIAL COMPANIES LLLP | $46.854.164 | 428.401 | 0,21% | Ações |
| Gotham Asset Management, LLC | $45.692.202 | 416.254 | 0,21% | Ações |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $45.629.084 | 415.679 | 0,21% | Ações |
| MEYER HANDELMAN CO | $43.310.961 | 394.561 | 0,20% | Ações |
| California Public Employees Retirement System | $43.063.978 | 392.311 | 0,20% | Ações |
| PineBridge Investments, L.P. | $42.927.515 | 345.243 | 0,20% | Ações |
| APG Asset Management N.V. | $41.881.772 | 436.216 | 0,19% | Ações |
| Mirae Asset Global Investments Co., Ltd. | $41.034.551 | 373.823 | 0,19% | Ações |
| Cetera Investment Advisers | $40.823.323 | 371.899 | 0,19% | Ações |
| PRINCIPAL FINANCIAL GROUP INC | $40.304.251 | 367.170 | 0,18% | Ações |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $37.237.324 | 385.999 | 0,17% | Ações |
| JANE STREET GROUP, LLC | $36.542.433 | 332.900 | 0,17% | Opção de venda |
| ALLIANCEBERNSTEIN L.P. | $35.703.643 | 370.101 | 0,16% | Ações |
| Connor, Clark & Lunn Investment Management Ltd. | $35.461.418 | 323.052 | 0,16% | Ações |
| Epoch Investment Partners, Inc. | $33.184.898 | 302.313 | 0,15% | Ações |
| SATURNA CAPITAL CORP | $33.095.765 | 301.501 | 0,15% | Ações |
| COMMONWEALTH EQUITY SERVICES, LLC | $32.160.578 | 292.981 | 0,15% | Ações |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $31.536.262 | 287.294 | 0,14% | Ações |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $31.120.015 | 283.502 | 0,14% | Ações |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $30.279.169 | 275.825 | 0,14% | Ações |
| Petrus Trust Company, LTA | $29.686.748 | 270.445 | 0,14% | Ações |
| STOREBRAND ASSET MANAGEMENT AS | $29.289.490 | 266.826 | 0,13% | Ações |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $28.715.064 | 261.593 | 0,13% | Ações |
| AVIVA PLC | $28.473.350 | 259.391 | 0,13% | Ações |
| Swedbank AB | $28.444.040 | 259.124 | 0,13% | Ações |
| Advisors Capital Management, LLC | $27.203.903 | 247.826 | 0,12% | Ações |
| Holowesko Partners Ltd. | $27.190.029 | 247.700 | 0,12% | Ações |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $27.018.788 | 245.865 | 0,12% | Ações |
| CANADA PENSION PLAN INVESTMENT BOARD | $26.782.343 | 243.986 | 0,12% | Ações |
| Man Group plc | $25.752.042 | 234.600 | 0,12% | Opção de compra |
| BANK OF MONTREAL /CAN/ | $25.539.308 | 232.662 | 0,12% | Ações |
| PNC Financial Services Group, Inc. | $25.415.158 | 231.531 | 0,12% | Ações |
| GATEWAY INVESTMENT ADVISERS LLC | $24.721.989 | 225.216 | 0,11% | Ações |
| STATE OF WISCONSIN INVESTMENT BOARD | $24.520.862 | 223.384 | 0,11% | Ações |
| PINEBRIDGE INVESTMENTS LLC | $23.755.655 | 216.413 | 0,11% | Ações |
| Mitsubishi UFJ Trust & Banking Corp | $23.398.463 | 213.159 | 0,11% | Ações |
| Mediolanum International Funds Ltd | $23.318.616 | 212.161 | 0,11% | Ações |
| CIBC WORLD MARKET INC. | $22.980.789 | 209.354 | 0,10% | Ações |
Executivos da empresa 82 insiders · 15 diretores · 6 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Elane B Stock | Group President, K-C Int'l | 3 de Maio de 2016 A | 20.699 | 0 | 0 | $0 |
| Joanne B Bauer | President, K-C Healthcare | 27 de Maio de 2014 S | 0 | 0 | 0 | $0 |
| Christian A. Brickman | Group President, K-C Int'l. | 17 de Fevereiro de 2014 F | 25.824 | 0 | 0 | $0 |
| Robert William Black | Group President | 25 de Abril de 2012 M | 20.203 | 0 | 0 | $0 |
| Steven R Kalmanson | Group President | 17 de Fevereiro de 2008 F | 104.296 | 0 | 0 | $0 |
| William Dudley Lehman | Group President | 8 de Junho de 2005 F | 41.538 | 0 | 0 | $0 |
| Robert P Van Der Merwe | Group President | 24 de Fevereiro de 2005 M | 21.465 | 0 | 0 | $0 |
| Lizanne C Gottung | SVP & Chief HR Officer | 31 de Outubro de 2016 A | 5.593 | 0 | 0 | $0 |
| Mark A Buthman | Executive Vice President | 19 de Novembro de 2015 S | 99.355 | 0 | 0 | $0 |
| Robert E Abernathy | Executive Vice President | 19 de Junho de 2014 A | 79.701 | 0 | 0 | $0 |
| Nancy S. Loewe | Chief Strategy Officer | 30 de Abril de 2014 A | 1.663 | 0 | 0 | $0 |
| Jan Bc Spencer | SVP, Continuous Improvement | 30 de Abril de 2012 M | 37.253 | 0 | 0 | $0 |
| Randy J Vest | Vice President and Controller | 2 de Julho de 2009 A | 83.007 | 0 | 0 | $0 |
| Ronald D Mccray | SVP, Law & Gov. Affairs | 7 de Agosto de 2007 M | 51.944 | 0 | 0 | $0 |
| Kathi P Seifert | Executive Vice President | 1 de Dezembro de 2003 M | — | 0 | 0 | $0 |
| Linda Johnson Rice | Conselheiro | 1 de Julho de 2015 A | 3.000 | 0 | 0 | $0 |
| John R Alm | Conselheiro | 2 de Abril de 2015 A | 0 | 0 | 0 | $0 |
| Craig G Sullivan | Conselheiro | 3 de Abril de 2012 A | — | 0 | 0 | $0 |
| Dennis R Beresford | Conselheiro | 4 de Abril de 2011 A | 1.500 | 0 | 0 | $0 |
| Pastora San Juan Cafferty | Conselheiro | 9 de Abril de 2007 G | 4.715 | 0 | 0 | $0 |
| Paul J Collins | Conselheiro | 2 de Abril de 2004 A | — | 0 | 0 | $0 |
| Patricia Corsi | — | 31 de Julho de 2026 M | 1.661 | 0 | 0 | $0 |
| Craig Slavtcheff | — | 31 de Julho de 2026 M | 6.651 | 0 | 0 | $0 |
| Andrew Scribner | — | 6 de Maio de 2026 S | 0 | 0 | 2 | $-719.290 |
| John Patrick Carmichael | — | 1 de Maio de 2026 A | — | 0 | 0 | $0 |
| Katy Chen | — | 1 de Maio de 2026 A | 8.362 | 0 | 2 | $-288.392 |
| Grant B Mcgee | — | 1 de Maio de 2026 A | 6.144 | 0 | 0 | $0 |
| Francesco Tinto | — | 1 de Maio de 2026 A | — | 0 | 0 | $0 |
| Tamera Fenske | — | 1 de Maio de 2026 A | 29.782 | 0 | 0 | $0 |
| Ehab Abou-Oaf | — | 1 de Maio de 2026 A | 54.593 | 0 | 0 | $0 |
| Stacey J. Panayiotou | — | 1 de Maio de 2026 A | — | 0 | 0 | $0 |
| Russell Torres | — | 1 de Maio de 2026 A | 86.294 | 0 | 0 | $0 |
| Jeffrey P. Melucci | — | 1 de Maio de 2026 A | 64.417 | 0 | 0 | $0 |
| Nelson Urdaneta | — | 1 de Maio de 2026 A | 45.285 | 0 | 0 | $0 |
| Michael D. Hsu | — | 1 de Maio de 2026 A | 332.816 | 0 | 0 | $0 |
| Todd Maclin | — | 9 de Fevereiro de 2026 P | 10.000 | 2 | 0 | $1.080.275 |
| Deeptha Khanna | — | 2 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| Joseph Romanelli | — | 2 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| Deirdre Mahlan | — | 2 de Janeiro de 2026 A | 25 | 0 | 0 | $0 |
| Christa S Quarles | — | 2 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| John Culver | — | 2 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| Jaime A Ramirez | — | 2 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| Sherilyn S Mccoy | — | 2 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| Sylvia M Mathews | — | 2 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| Mark T Smucker | — | 2 de Janeiro de 2026 A | 827 | 0 | 0 | $0 |
| Mae Jemison | — | 2 de Janeiro de 2026 A | 0 | 0 | 0 | $0 |
| Dunia A Shive | — | 2 de Janeiro de 2026 A | — | 0 | 0 | $0 |
| Zackery A Hicks | — | 4 de Agosto de 2025 S | 14.321 | 0 | 0 | $0 |
| Andrew Drexler | — | 1 de Maio de 2025 M | 9.187 | 0 | 0 | $0 |
| Sandra R Karrmann | — | 1 de Maio de 2025 M | 25.493 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 1 participação
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Kimberly-Clark Corporation | 19 de Outubro de 2009 | — | Declaração inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 215 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| FLV · AMERICAN CENTURY ETF TRUST | 2,23% | 80.510 NS | 31 de Maio de 2026 | N-PORT |
| WBIG · Absolute Shares Trust | 2,03% | 5.070 NS | 30 de Junho de 2026 | N-PORT |
| SNPD · DBX ETF Trust | 1,86% | 498 NS | 29 de Maio de 2026 | N-PORT |
| QDIV · Global X Funds | 1,69% | 5.681 NS | 31 de Maio de 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 1,50% | 5.920 NS | 30 de Abril de 2026 | N-PORT |
| KNG · First Trust Exchange-Traded Fund IV | 1,48% | 507.548 NS | 30 de Abril de 2026 | N-PORT |
| NOBL · ProShares Trust | 1,48% | 1.679.331 NS | 31 de Maio de 2026 | N-PORT |
| TMDV · ProShares Trust | 1,47% | 665 NS | 31 de Maio de 2026 | N-PORT |
| PAYR · Federated Hermes ETF Trust | 1,38% | 5.116 NS | 30 de Abril de 2026 | N-PORT |
| VALQ · AMERICAN CENTURY ETF TRUST | 1,24% | 44.012 NS | 31 de Maio de 2026 | N-PORT |
| UGE · ProShares Trust | 1,18% | 1.415 NS | 31 de Maio de 2026 | N-PORT |
| FSTA · FIDELITY COVINGTON TRUST | 1,15% | 167.470 NS | 30 de Abril de 2026 | N-PORT |
| GXPS · Global X Funds | 1,09% | 6.661 NS | 31 de Maio de 2026 | N-PORT |
| FDIV · EA Series Trust | 1,00% | 7.421 NS | 30 de Abril de 2026 | N-PORT |
| FXG · First Trust Exchange-Traded AlphaDE… | 0,83% | 20.689 NS | 30 de Abril de 2026 | N-PORT |
| SCHD · SCHWAB STRATEGIC TRUST | 0,81% | 7.927.703 NS | 31 de Maio de 2026 | N-PORT |
| FLCV · Federated Hermes ETF Trust | 0,80% | 7.937 NS | 31 de Maio de 2026 | N-PORT |
| MFSV · MFS Active Exchange Traded Funds Tr… | 0,78% | 37.869 NS | 31 de Maio de 2026 | N-PORT |
| FLRG · FIDELITY COVINGTON TRUST | 0,71% | 20.447 NS | 30 de Abril de 2026 | N-PORT |
| UPSD · ETF Series Solutions | 0,68% | 6.949 NS | 30 de Abril de 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,65% | 680 NS | 31 de Maio de 2026 | N-PORT |
| FLAG · Global X Funds | 0,59% | 99 NS | 30 de Abril de 2026 | N-PORT |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,52% | 68.331 NS | 30 de Abril de 2026 | N-PORT |
| KRMA · Global X Funds | 0,49% | 6.033 NS | 31 de Maio de 2026 | N-PORT |
| QDEF · FlexShares Trust | 0,49% | 26.145 NS | 30 de Abril de 2026 | N-PORT |
| RCGE · EA Series Trust | 0,46% | 4.411 NS | 30 de Abril de 2026 | N-PORT |
| GMOV · GMO ETF Trust | 0,46% | 4.276 NS | 31 de Maio de 2026 | N-PORT |
| SPXD · DBX ETF Trust | 0,41% | 282 NS | 31 de Maio de 2026 | N-PORT |
| FLCC · Federated Hermes ETF Trust | 0,40% | 5.000 NS | 31 de Maio de 2026 | N-PORT |
| EQIN · Columbia ETF Trust I | 0,36% | 9.995 NS | 30 de Abril de 2026 | N-PORT |
| DUHP · Dimensional ETF Trust | 0,34% | 391.944 NS | 30 de Abril de 2026 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 0,32% | 38.811 NS | 30 de Abril de 2026 | N-PORT |
| FBCV · FIDELITY COVINGTON TRUST | 0,30% | 4.930 NS | 30 de Abril de 2026 | N-PORT |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,30% | 5.294 NS | 30 de Abril de 2026 | N-PORT |
| FQAL · FIDELITY COVINGTON TRUST | 0,30% | 41.458 NS | 30 de Abril de 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,27% | 11.306 NS | 31 de Maio de 2026 | N-PORT |
| QLC · FlexShares Trust | 0,26% | 23.520 NS | 30 de Abril de 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,26% | 3.616 NS | 30 de Abril de 2026 | N-PORT |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0,25% | 192.842 NS | 30 de Abril de 2026 | N-PORT |
| FDLO · FIDELITY COVINGTON TRUST | 0,23% | 33.297 NS | 30 de Abril de 2026 | N-PORT |
| DEUS · DBX ETF Trust | 0,21% | 5.968 NS | 29 de Maio de 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,21% | 4.825 NS | 30 de Abril de 2026 | N-PORT |
| GSEW · Goldman Sachs ETF Trust | 0,19% | 35.176 NS | 31 de Maio de 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,17% | 25.469 NS | 30 de Abril de 2026 | N-PORT |
| ESG · FlexShares Trust | 0,15% | 2.015 NS | 30 de Abril de 2026 | N-PORT |
| OUSA · ALPS ETF Trust | 0,15% | 11.674 NS | 31 de Maio de 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0,13% | 8.004 NS | 30 de Abril de 2026 | N-PORT |
| HAPI · Harbor ETF Trust | 0,13% | 6.266 NS | 30 de Abril de 2026 | N-PORT |
| QARP · DBX ETF Trust | 0,13% | 996 NS | 29 de Maio de 2026 | N-PORT |
| DFVX · Dimensional ETF Trust | 0,12% | 5.733 NS | 30 de Abril de 2026 | N-PORT |